Hox Therapeutics and Vernalis announce a drug discovery collaboration in oncology
- Written by PR Newswire
![]() |
CHENGDU, China, Feb. 20, 2024 /PRNewswire/ -- Hox Therapeutics Ltd ("Hox") a private biotechnology company developing highly targeted cancer therapies and Vernalis (R&D) Ltd ("Vernalis"), a fully owned subsidiary of HitGen Inc., are pleased to announce a collaboration to identify inhibitors against an undisclosed oncology target.
Under the...
Read more: Hox Therapeutics and Vernalis announce a drug discovery collaboration in oncology















